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Abstract
U87MG is a commonly studied grade IV glioma cell line that has been analyzed in at least 1,700 publications over four
decades. In order to comprehensively characterize the genome of this cell line and to serve as a model of broad cancer
genome sequencing, we have generated greater than 306genomic sequence coverage using a novel 50-base mate paired
strategy with a 1.4kb mean insert library. A total of 1,014,984,286 mate-end and 120,691,623 single-end two-base encoded
reads were generated from five slides. All data were aligned using a custom designed tool called BFAST, allowing optimal
color space read alignment and accurate identification of DNA variants. The aligned sequence reads and mate-pair
information identified 35 interchromosomal translocation events, 1,315 structural variations (.100 bp), 191,743 small
(,21 bp) insertions and deletions (indels), and 2,384,470 single nucleotide variations (SNVs). Among these observations, the
known homozygous mutation in PTEN was robustly identified, and genes involved in cell adhesion were overrepresented in
the mutated gene list. Data were compared to 219,187 heterozygous single nucleotide polymorphisms assayed by Illumina
1M Duo genotyping array to assess accuracy: 93.83% of all SNPs were reliably detected at filtering thresholds that yield
greater than 99.99% sequence accuracy. Protein coding sequences were disrupted predominantly in this cancer cell line due
to small indels, large deletions, and translocations. In total, 512 genes were homozygously mutated, including 154 by SNVs,
178 by small indels, 145 by large microdeletions, and 35 by interchromosomal translocations to reveal a highly mutated cell
line genome. Of the small homozygously mutated variants, 8 SNVs and 99 indels were novel events not present in dbSNP.
These data demonstrate that routine generation of broad cancer genome sequence is possible outside of genome centers.
The sequence analysis of U87MG provides an unparalleled level of mutational resolution compared to any cell line to date.
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Introduction
Grade IV glioma, also called glioblastoma multiforme (GBM), is
the most common primary malignant brain tumor with about
16,000 new diagnoses each year in the United States. While the
number of cases is relatively small, comprising only 1.35% of
primary malignant cancers in the US [1], GBMs have a one-year
survival rate of only 29.6%, making it one of the most deadly types
of cancer [2]. Recent clinical studies demonstrate improved
survival with a combination of radiation and Temozolomide
chemotherapy, but median survival time for GBM patients who
receive therapy is only 15 months [3]. Due to its highly aggressive
nature and poor therapeutic options, understanding the genetic
etiology of GBM is of great interest and therefore, GBM has been
selected as one of the three initial cancer types to be thoroughly
studied in the TCGA program [4].
To that end, numerous cell line models of GBM have been
established and used in vast numbers of studies over the years. It is
well recognized that cell line models of human disorders, especially
cancers, are an important resource. While these cell lines are the
basis of substantial biological insight, experiments are currently
performed in the absence of genome-wide mutational status as no
cell line that models a human disease has yet had its genome fully
sequenced. Here, we have sequenced the genome of U87MG, a
long established cell line derived from a human grade IV glioma
used in over 1,700 publications [5]. A wide range of biological
information is known about this cell line. The U87MG cell line is
known to have a highly aberrant genomic structure based on
karyotyping, SKY [6], and FISH [7]. However, these methods
neither provide the resolution required to visualize the precise
breakpoint of a translocation event, nor are they generally capable
of identifying genomic microdeletions (deletions on the order of a
megabase or less in size) in a whole genome survey of structural
variation. SNP genotyping microarrays can be used to detect
regions of structural variation in the forms of loss of heterozygosity
(LOH) and copy number (CN) based on probe intensity, but do
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U87MG, the genome was genotyped by Illumina Human 1M-
Duo BeadChip microarray. In spite of being cultured indepen-
dently for several years, the regions of LOH and the CN state of
our U87MG genome matched exactly with data retrieved from
the Sanger COSMIC database for U87MG [8], which had been
assayed on an Affymetrix Genome-Wide Human SNP Array 6.0.
This suggests that although U87MG bears a large number of
large-scale chromosomal aberrations, it has been relatively stable
for years and is not rapidly changing. This suggests that prior work
on U87MG may be reinterpreted based on the whole genome
sequence data presented here.
The first draft of the consensus sequence of the human genome
was reported in 2001 [9,10]. The first individual human diploid
sequence was sequenced using capillary-based Sanger sequencing
[11]. Since then, a few additional diploid human genomes have
been published utilizing a variety of massively parallel sequencing
techniques to sequence human genomes to varying degrees of
coverage, variant discovery, and quality typically costing well over
$200,000 and several machine months of operation [12–16]. For
the sequencing of U87MG, we utilized ABI SOLiD technology,
which uses a ligation-based assay with two-base color-encoded
oligonucleotides that has been demonstrated to allow highly
accurate single nucleotide variant (SNV) and insertion/deletion
(indel) detection [17]. Additionally, long mate-paired genomic
libraries with a mean insert size of 1–2kb allowed higher clone
coverage of the genome, which improved our ability to identify
genomic structural variations such as interchromosomal translo-
cations and large deletions. While longer insert sizes would
improve resolution of some structural variants, during genomic
shearing the highest density of large fragments occurs at 1.5kb,
allowing a sufficiently complex library to be generated from only
10 micrograms of genomic DNA while still being well powered to
identify structural variations. Here, we demonstrate that aligning
the two-base color-encoding data with BFAST software and
decoding during alignment allows for highly sensitive detection of
indels, which have in the past been difficult to detect by short read
massively parallel sequencing.
For cancer sequencing, it is important to assess not only SNVs,
but indels, structural variations and translocations, and it is
preferable to extract this information from a common assay
platform. A major characteristic of the U87MG cell line that
differentiates it from the samples used in other whole genome
sequencing projects published thus far is its highly aberrant
genomic structure. Due to its heavily rearranged state, we
thoroughly and accurately assessed each of these major classes of
mutations and demonstrated that small indels, large microdele-
tions and interchromosomal translocations are actually the major
categories of mutations that affect known genes in this cancer cell
line. These analyses provide a model for other genome sequencing
projects outside major genome centers of how to both thoroughly
sequence and assess the mutational state of whole genomes.
Results
Data Production
From ten micrograms of input genomic DNA, we performed
two and a half full sequencing runs on the ABI SOLiD Sequencing
System, for a total of five full slides of data [17]. Utilizing the ABI
long mate-pair protocol, we produced 1,014,984,286 raw 50bp
mate-paired reads (101.5Gb). In some cases the bead was
recognized by the imaging software for only one read, thereby
producing an additional 120,691,623 single end reads (6.0Gb). In
aggregate, we generated a total of 107.5Gb of raw data (Table 1).
We also performed an exon capture approach designed to
sequence the exons of 5,253 genes (10.7Mb) annotated in the
Wellcome Trust Sanger Institute Catalogue of Somatic Mutations
in Cancer (COSMIC) V38 [8], Cancer Gene Census, Cancer
Genome Project Planned Studies and The Cancer Genome Atlas
(TCGA) [4] GBM gene list using a custom-created Agilent array.
This approach used the Illumina GAII sequencing system [18] to
sequence captured DNA fragments using a paired end sequencing
protocol. This resulted in 9,948,782 raw 76bp paired end reads
(1.51Gb), and a mean base coverage of 29.56. These reads were
used to calculate concordance rates with the larger whole genome
sequence dataset.
The Blat-like Fast Accurate Search Tool (BFAST) [19] version
0.5.3 was used to align 107.5Gb of raw color space reads to the
color space conversion of the human genome assembly hg18 from
Author Summary
Glioblastoma has a particularly dismal prognosis with
median survival time of less than fifteen months. Here, we
describe the broad genome sequencing of U87MG, a
commonly used and thus well-studied glioblastoma cell
line. One of the major features of the U87MG genome is
the large number of chromosomal abnormalities, which
can be typical of cancer cell lines and primary cancers. The
systematic, thorough, and accurate mutational analysis of
the U87MG genome comprehensively identifies different
classes of genetic mutations including single-nucleotide
variations (SNVs), insertions/deletions (indels), and trans-
locations. We found 2,384,470 SNVs, 191,743 small indels,
and 1,314 large structural variations. Known gene models
were used to predict the effect of these mutations on
protein-coding sequence. Mutational analysis revealed 512
genes homozygously mutated, including 154 by SNVs, 178
by small indels, 145 by large microdeletions, and up to 35
by interchromosomal translocations. The major mutational
mechanisms in this brain cancer cell line are small indels
and large structural variations. The genomic landscape of
U87MG is revealed to be much more complex than
previously thought based on lower resolution techniques.
This mutational analysis serves as a resource for past and
future studies on U87MG, informing them with a thorough
description of its mutational state.
Table 1. Genome sequencing summary.
Sequencing Libraries 1
SOLiD Runs (Slides) 2.5 (5)
Strategy 2650
Mate-paired reads passing quality
filter (total bases)
1,014,984,286 (101.5Gb)
Single-end reads passing quality
filter (total bases)
120,691,623 (6.0Gb)
Mate-paired reads uniquely aligned by
BFAST (bases)
390,064,184 (39.06Gb)
Unpaired reads uniquely aligned by
BFAST (bases)
266,635,829 (13.33Gb)
Single-end reads uniquely aligned by
BFAST (bases)
62,336,824 (3.12Gb)
Total bases uniquely aligned by BFAST 55.51Gb
doi:10.1371/journal.pgen.1000832.t001
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edu/goldenPath/hg18/bigZips/, based on the March 2006 NCBI
build 36.1). Duplicate reads, typically from the same initial PCR
fragment during genomic library construction, were inevitable and
accounted for 16.4% of the total aligned data. These were
removed using the alignment filtering utility in the DNAA package
(http://dnaa.sourceforge.net). A total of 390,604,184 paired end
reads (39.06Gb), 266,635,829 (13.33Gb) unpaired reads, and
62,336,824 (3.12Gb) single end reads were successfully mapped to
a unique location in the reference genome with high confidence
for a total of 55.51Gb of aligned sequence (Table 1). For the exon
capture dataset, we uniquely aligned 8,142,874 paired end reads
(1.2Gb) and 1,097,000 (83Mb) unpaired reads for a total of
1.32Gb of raw aligned sequence (Table 2). Using the ABI SOLiD
reads, we identified small insertions and deletions (indels), single
nucleotide variants (SNVs), and structural variants such as large-
scale microdeletions and translocation events. The exon capture
Solexa reads were used to validate SNVs identified in the SOLiD
sequencing.
The overall pattern of base sequence coverage from the shotgun
reads changes across the genome, and as expected is highly
concordant with the copy number state as determined by Illumina
1M Duo and Affymetrix 6.0 SNP analysis (Figure 1). Regions of
two normal copies, such as chromosome 3, showed even base
sequence coverage across their entire length (12.4 reads/base,
excluding centromeric and telomeric regions which are not
represented accurately in hg18). Meanwhile, regions with one-
copy state according to the SNP chip, such as the distal q-arm of
chr11 and the distal p-arm of chr6, show about half the base
sequence coverage (7.2 reads/base) as a predicted two-copy
region. Likewise, predicted three-copy state regions, such as the
distal q-arm of chr13, show about 1.5 times the base sequence
coverage of a predicted two-copy region. A complete deletion
spanning the region on chromosome 9 that includes the CDKN2A
gene is also seen in both the SNP chip and ABI SOLiD base
sequence coverage. These data show at a very large scale that
sequence placement is generally correct and supports the copy
number state calls from the array based data.
Variant Discovery
Single nucleotide variants (SNVs) and small insertions and
deletions ranging from 1 to 20 bases (indels) were identified from
the alignment data using the MAQ consensus model [20] as
implemented in the SAMtools software suite [21]. SAMtools
produced variant calls, zygosity predictions, and a Phred-scaled
probability that the consensus is identical to the reference. To
improve the reliability of our variant calls, variants were required
to have a Phred score of at least 10 and further needed to be
observed greater than or equal to 4 but less than 60 times and at
least once on each strand.
In total, we identified 2,384,470 SNVs meeting our filtering
criteria. Of these, 2,140,848 (89.8%) were identified as exact
matches to entries in dbSNP129 [22]. Exact matches had both the
variant and observed alleles in the dbSNP entry, allowing for the
discovery of novel alleles at known SNP locations. In total,
243,622 SNVs (10.2%) were identified as novel events not
previously recorded in dbSNP 129. This rate of novel variant
discovery is consistent with other whole human normal genome
sequences of European ancestry relative to dbSNP [12]. These
SNVs were further characterized based on zygosity predictions
from the MAQ consensus model, separating SNVs into homozy-
gous or heterozygous categories (Table 3). The observed diversity
value for SNVs (hSNV, number of heterozygous SNVs/number of
base pairs) across autosomal chromosomes was 4.4610
24, which is
generally consistent with the normal human genome variation
rate.
For small (,21bp) insertions and deletions, 191,743 events were
detected with 116,964 not previously documented in dbSNP 129.
The same criteria as used for SNVs was used for determining if an
indel was novel and they were further classified as homozygous or
heterozygous using the SAMtools variant caller (Table 4). The
observed diversity value (hindel, number of heterozygous indels/
number of base pairs) across autosomal chromosomes was
0.38610
24.
A subset of 38 variants meeting genome-wide filtering criteria,
including a 20-base deletion, was tested by PCR and Sanger
sequencing with 34 being validated. In summary, 85.2% of SNVs
(23/27), and 100% of small insertions (3/3), deletions (4/4),
translocations (3/3) and microdeletions (1/1) were validated in this
manner (Table S1). While this is a small sample, it demonstrates
an overall low false positive rate.
Indel Size Distribution
The size distribution of indels identified in U87MG is generally
consistent with previous studies on coding and non-coding indel
sizes in non-cancer samples [23–25]. Small deletion sizes ranged
from 1 to 20 bases in size and their distribution approximates a
power law distribution in concordance with previous findings [23]
(Figure 2A). There is a small deviation from the power law
distribution with an excess of 4-base indels in U87MG’s non-
coding regions (Figure 2A, red bars) [11,26].
A similar trend is seen with insertions in non-coding sequence
with the maximum observed insertion size of 17 bases (Figure 2B,
red bars). The maximum insertion size observed is less than the
maximum deletion size because it is easier to align longer deletions
than it is to align insertions. Some small insertions and deletions
are likely to be larger than the upper limit of 17 and 20 bases
actually observed, but the 50-base read length limits the power to
align such reads directly.
In coding regions, there is a bias towards events that are
multiples of 3-bases in length that maintain the reading frame
despite variant alleles, suggesting that many of these are
polymorphisms (Figure 2A-deletions, Figure 2B-insertions, blue
bars). In non-coding regions, only 10.8% of indels are a multiple of
3 bases in size, while in coding regions, 27.0% are 3, 6, 9, 12 or 15
bases in size. This trend is expected based on past observations of
non-cancer samples [11,26].
Table 2. Exon capture sequencing summary.
Sequencing Libraries 1
Illumina Runs (Lanes) 1/8 (1)
Strategy 2676
Number of bases targeted 10752923
Mate-paired reads passing quality filter
(total bases)
9,948,782 (1.51Gb)
Mate-paired reads uniquely aligned by
BFAST (bases)
8,142,874 (1.2Gb)
Unpaired reads uniquely aligned by BFAST
(bases)
1,097,000 (83Mb)
Total bases uniquely aligned by BFAST 1.32Gb
Total targeted bases sequenced 317,017,503
Mean coverage within targeted bases 29.56
doi:10.1371/journal.pgen.1000832.t002
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Observed SNV base substitution patterns were consistent with
common mutational phenomena in both coding sequences and
genome wide. As expected, the predominant nucleotide substitu-
tion seen in SNVs is a transition, changing purine for purine (A
,-.G) or pyrimidine for pyrimidine (C,-.T). Previous studies
have observed that two out of every three SNPs are transitions as
opposed to transversions [27], and we observed that 67.4% of our
SNVs were transitions, while 32.6% were transversions, a 2.07:1
ratio. (Figure 3) However, in coding regions, there appears to be
an increase in C-.T/G-.A transitions and a decrease in T-.C/
A-.G transitions, whereas genome-wide these transitions were
approximately equivalent.
Estimation of Genomic Coverage
To assess the coverage depth of the U87MG genome sequence,
we followed Ley at al. [13] and required detection of both alleles at
most positions in the genome. We utilized the Illumina 1M-Duo
BeadChip to find reliably sequenced positions in the genome with
an understanding that this may lead to bias towards more unique
regions of the genome. In order to best use the SNP genotyping
array data, we included only those regions that are diploid based
on normal frequency of heterozygous calls and copy number
assessment. This effectively permitted us to use the heterozygous
calls for assessing accuracy of the short read data for variant calling
(Figure 1). Only SNPs both observed to be heterozygous and that
the Illumina genotyping chip called ‘high quality’ were used,
which provided a total of 219,187 high quality heterozygous SNPs
for comparison. 99.71% of these were sequenced at least once.
After applying variant detection filtering criteria (see Materials and
Methods) and assessing concordance between the sequence calls
and genotyping array calls, 93.71% of the genome was sequenced
at sufficient depth to call both alleles of the diploid genome. This is
roughly equivalent to the likelihood of sufficient sampling of the
Figure 1. SNP chip and base sequence coverage compared. Circos [36] was used to plot base sequence coverage from ABI sequencing as a
histogram (the outermost plot, green and black) alongside dot plots of the LogR-ratio (middle plot, blue) and B-allele frequency (innermost plot, red)
from the Illumina Human 1M Duo BeadChip microarray. LogR-ratio represents copy number (CN) and B-allele frequency represents loss of
heterozygosity (LOH).
doi:10.1371/journal.pgen.1000832.g001
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excluded.
Notably, a variant allele was observed at every position called
heterozygous by SNP chip, while a reference allele was observed at
201,414 (97.94%) positions. In other words, the SNV detection
algorithm uniformly miscalled the homozygous variant allele.
Filtering for quality causes a bias toward identifying SNVs at sites
that have higher coverage. That said, after SNV quality filtering,
diploid coverage of the cytogenetically normal portions of the
genome was 10.856for each allele, which is clearly adequate for
calling over 90% of the base variant positions on each allele at
high accuracy.
Because the positions of the genome included on SNP arrays is
not a random sampling of the genome, we also assessed mapping
coverage genome-wide. Of all bases in the haploid genome, 78.9%
of the whole reference genome was covered by at least one reliably
placed read. Of that portion of the genome, 91.9% of all bases
were effectively sequenced based on passing variant calling filters
(Phred.10, .46 coverage, ,606 coverage). Thus, a total of
72.5% of the whole genome was sequenced, including repeats and
duplicated regions, which is typical of short sequence shotgun
approaches.
Exon Capture Cross-Validation of Sequence Variants
10.9Mb of genomic sequence was targeted consisting of the
amino acid encoding exons of 5,235 genes and were sequenced to
a mean coverage of 306 using the Illumina GAII sequencer.
Given the larger variability of coverage from the capture data,
only a subset of these bases (8.5Mb) was evaluable to determine the
false positive variant detection rate from the complete genomic
sequence data. This region contained 1,621 SNPs present in
dbSNP129. Within the 8.5Mb of common and well-covered
sequence in the genomic sequence data and the capture sequence,
there were 1,780 SNVs called from the genomic sequence. The
same non-reference allele was concordantly observed at 1,631
positions within the capture data. At 149 positions, the non-
Table 3. SNV filtering and quantification.
SNV Classification Total In dbSNP 129 Not in dbSNP 129
Variants meeting filter criteria 2,384,470 2,140,848 243,622
Synonymous or not coding region 2,375,812 2,133,226 242,586
Coding region & non-synonymous 8,658 7,622 1,036
Splice site mutations 151 132 19
Heterozygous splice site mutations 62 47 15
Homozygous splice site mutations 89 85 4
Premature stop 134 93 41
Heterozygous premature stop 82 48 34
Homozygous premature stop 52 45 7
Non-synonymous 8,538 7,518 1,020
Heterozygous non-synonymous 4,005 3,134 871
Homozygous non-synonymous 4,533 4,384 149
doi:10.1371/journal.pgen.1000832.t003
Table 4. Indel filtering and quantification.
Indel Classification Total In dbSNP 129 Not in dbSNP 129
Variants meeting filter criteria 191,743 74,779 116,964
Synonymous or not coding region 191,359 74,643 116,716
Coding region & non-synonymous 384 136 248
Splice site mutations 84 34 50
Heterozygous splice site mutations 20 7 13
Homozygous splice site mutations 64 27 37
Heterozygous premature stop 91 15 76
Homozygous premature stop 94 40 54
Heterozygous non-synonymous 168 45 123
Homozygous non-synonymous 193 86 107
Heterozygous frameshift 141 33 108
Homozygous frameshift 179 80 99
Heterozygous in-frame indels 26 11 15
Homozygous in-frame indels 14 5 9
doi:10.1371/journal.pgen.1000832.t004
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reference allele was detected. However, the mean coverage at
these 149 positions was significantly lower than that of the other
1,631 positions (p=0.0003), suggesting that the non-reference
allele was not adequately covered and is under called in the
capture data. Moreover, of the 1,621 dbSNPs in the region, the
capture adequately covered only 1,515. In these data there was a
bias for the pull down data to under observe the non-reference
allele (Figure S1). The 106 dbSNP positions detected in the ABI
whole genome sequence dataset were observed to all call the
reported alternate allele from dbSNP. In theory, if these were
errors, then non-reference base calls should be randomly
distributed to the three alternate base calls. Thus, no discrepancies
are reliably identified within the dbSNP overlap when a variant
was called in the ABI genomic sequence data.
There were a total of 100 novel SNVs detected in the ABI
genomic sequence dataset that were also very well evaluated in the
Illumina pull down data with at least 20 high quality Illumina
reads, such that the ABI sequence could be well validated. Of
these, 2 of the 100 discovered variants in the genomic sequence
dataset were not observed in the Illumina pull down sequencing
dataset. Thus, of the entire 8.5mb interval there are 2
unconfirmed variants for an estimated false positive error rate of
about 3610
27 for the whole interval. Alternatively viewed, there
were 100 novel SNVs, with a 2% error rate in those novel
positions. Thus, the de novo false discovery rate may be as high as
2%. Extrapolating to the whole set of 243,622 novel SNVs, we
expect up to 4,872 false positives SNVs. These observations are
roughly concordant with a sampling of 37 novel SNVs (not in
dbSNP) in the whole genome set selected for testing by Sanger
sequencing. Of these, 34 out of 37 (92%) were validated.
Individual Genome Comparison
There are now several publicly available complete genomes
sequenced on next generation platforms. We compared the SNVs
discovered in U87MG to two of these published genomes: the
James D. Watson genome [12] and the first Asian genome
(YanHuang) [14]. Further, we simultaneously compared each of
these to dbSNP version 129 [22]. Compared with dbSNP, 10.2%
of U87MG SNVs, 9.5% of Watson SNVs, and 12.0% of
YanHuang SNVs were not present within dbSNP (Figure 4). As
U87MG was derived from a patient of Caucasian ancestry, which
is confirmed by genotyping, it is unsurprising to see a higher
overlap with dbSNP for U87MG than for YanHuang. Between
the three genomes themselves, 44.7% of U87MG SNVs
overlapped with Watson SNVs while 60.0% of SNVs were in
common with YanHuang SNVs. Only 8.5% of dbSNP SNVs were
shared between Watson and U87MG, while 11.3% of them were
shared between YanHuang and U87MG. Thus, there is not a
substantially higher amount of SNVs in the U87MG cancer
genome relative to normal genomes.
Structural Variation Identification
We utilized the predictable insert distance of mate-paired
sequence fragments to directly observe structural variations in
U87MG. Our target insert size of 1.5kb gave us a normal
distribution of paired end insert lengths ranging from 1kb to 2kb
with median around 1.25kb and mean around 1.45kb in the actual
sequence data (Figure S2). We identified 1,314 large structural
variations, including 35 interchromosomal events, 599 complete
homozygous deletions (including a large region on chromosome 9
containing CDKN2A/B, which commonly experience homozy-
gous deletions in brain cancer), 361 heterozygous deletion events,
and 319 other intrachromosomal events (Table 5). The 599
complete microdeletions summed up to approximately 5.76Mb of
total sequence, while the 361 heterozygous microdeletions
summed to 5.36Mb of total sequence. Most of the microdeletions
were under 2kb in total size. Because of the high sequence
Figure 2. Small insertion/deletion size distribution. (A) Distribu-
tion of small deletion sizes as a percent of total, comparing amino-acid
encoding deletions (blue) with non-coding deletions (red). (B)
Distribution of small insertion sizes as a percent of total, comparing
amino-acid encoding insertions (blue) with non-coding insertions (red).
doi:10.1371/journal.pgen.1000832.g002
Figure 3. Base substitution frequencies. Ratio of specific
nucleotide substitutions as a percent of total single nucleotide variants,
comparing SNVs in coding regions (blue) to SNVs genome-wide (red).
doi:10.1371/journal.pgen.1000832.g003
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average of 138 mate pair reads. Mispairing of the mate pairs did
occur occasionally due to molecular chimerism in the library
fabrication process, but such reads occur at a low frequency (,1/
40 of the reads). Thus, the true rearrangement/deletion events
were highly distinct from noise in well-mapped sequences.
Interchromosomal events included translocations and large
insertion/deletion events where one part of a chromosome was
inserted into a different chromosome, sometimes replacing a
segment of DNA. All together, these structural variations show a
highly complex rearrangement of genomic material in this cancer
cell line (Figure 5). All identified structural variants are
summarized in Table S2. We note as well that even when
breakpoints are within genome-wide common repeats there can be
sufficient mapping information to reliably identify the transloca-
tion breakpoint (Figure S3).
The thirty-five interchromosomal events often coincided with
positions of copy number change based on the average base
coverage (Figure 5). Figure 6 shows two interchromosomal events
between chromosomes 2 and 16. The events on chromosome 16
are less than 1kb apart while those on chromosome 2 are about
160kb apart. Based on the average base coverage, there appears to
be a loss of genomic material between the event boundaries on
their respective chromosomes, shifting from two to one copy.
Although we are unable to determine the origin of such an event,
it appears that there was an interchromosomal translocation
between chromosomes 2 and 16 with a loss of the DNA between
the identified regions on each chromosome.
A subset of 3 translocations were confirmed by amplifying DNA
from the breakpoint-spanning region by polymerase chain
reaction and sequencing by dideoxy Sanger sequencing (Table
S1). Each confirmed the predicted breakpoint to within 100
nucleotides of the correct position. In a subset of cases, unmapped
short read fragments could be identified from the shotgun short
read data that span the breakpoint and are concordant at base
resolution with Sanger sequencing of PCR amplified product
spanning the breakpoint
Genes Affected by Mutations in Coding Sequence
The SNVs and indels identified in U87MG were assessed for
their potential to affect protein-coding sequence. We considered
variants predicted to be homozygous and to affect the coding
sequence of a gene through a frameshift, early termination, intron
splice site, or start/stop codon loss mutation as causing a complete
loss of that protein. We chose to focus on homozygous null
mutations for two major reasons. First, this is an interesting set of
genes that we can predict from the whole genome data are non-
functional within this commonly used cell line. Although
heterozygous mutations can certainly affect gene products in
multiple ways, it is difficult to assess their effect from genomic data
alone. Second, by cross-referencing such null mutations with
known regions of common mutation in gliomas we can pick out
specific candidates that are of interest to the glioma community.
Of the 2,384,470 SNVs and 191,743 small indels in U87MG, a
total of 332 genes are predicted to have loss-of-function,
homozygous mutations as a consequence of small variants (Table
S3). Of these, 225 genes contained variants matching alleles
annotated in dbSNP (version 129), while 107 contained novel
variants not observed in dbSNP.
We further divided these homozygous mutant genes by variant
type. Of genes mutated by SNVs, 146 contained variants present
Figure 4. Individual genome comparison. (A) Venn diagram
showing overlap in SNVs among the U87 genome, the Watson genome,
and dbSNP 129. (B) Venn diagram showing overlap in SNVs among the
U87 genome, the YanHuang genome, and dbSNP 129.
doi:10.1371/journal.pgen.1000832.g004
Table 5. Structural variations detected.
Type # of events # that span genes (%) # of affected genes (%)
Complete deletion 599 95 (15.9%) 145
Heterozygous deletion 361 58 (16.0%) 91
Interchromosomal translocation 35 32 (91.4%) 35
Other intrachromosomal events 319 146 (45.8%) 166
doi:10.1371/journal.pgen.1000832.t005
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dbSNP. The ratio of known SNPs causing loss-of-function
mutations to total known SNPs (146/2,140,848=6.82610
25)
was not significantly different from the ratio of novel SNVs causing
loss-of-function mutations over total novel SNVs (8/
243,622=3.28610
25; p=0.04). This indicates that many of the
possible de novo point mutations may indeed be rare inherited
variants made homozygous by chromosomal loss of the normal
allele.
In contrast to the trend in SNVs, small indels that homozy-
gously mutated genes were more often novel. There were 79 genes
predicted homozygously mutated by indel variants reported in
dbSNP while 99 were predicted mutated by novel indels. Despite
this trend, however, there was not a significant enrichment of
deleterious indels among the novel indels (99/
191,743=5.16610
24) compared to the known indels (79/
116,964=6.75610
24; p=0.08) This suggests that the difference
in ratios of novel versus documented SNVs (8 vs. 146) and indels
(99 vs. 79) is the result of compositional bias in dbSNP129, which
contains a far greater number of SNPs compared to indels.
We also assessed the structural variants in U87MG for whether
or not they were likely to affect a gene. Two different criteria were
used to determine if translocations and microdeletions impacted a
coding region, both predicted to produce an aberrant or
Figure 5. Structural variations in U87MG. Structural variations detected by whole genome sequencing in the U87MG genome are plotted in the
Circos program. Orange lines linking two chromosomes represent the 35 interchromosomal translocations. Blue lines around the edge of the circle
represent microdeletions and intrachromosomal translocations. The outermost histogram represents sequence coverage and demonstrates how the
boundaries of changes in coverage typically coincide with a significant structural variation.
doi:10.1371/journal.pgen.1000832.g005
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identified 35 genes affected by interchromosomal translocations,
145 affected by complete deletions, 91 affected by heterozygous
deletions and 166 affected by other intrachromosomal transloca-
tions (Table 4).
Interchromosomal translocation events were significantly en-
riched for occurring at positions where they would affect genes
with 32 out of 35 events (91.4%) occurring within 1kb of a gene
(p,0.0001), while only 44.1% of the reference genome is within
1kb of a known gene. In total, intrachromosomal events did not
display this enrichment with 145/319 (45.5%) falling within 1kb of
a gene (p=0.67). However, we ran a set of simulations to assess
whether microdeletions were enriched to overlap exons because
we noted that 585 of our 599 complete microdeletions were less
than 10kb in length with a mean size of 1.8kb. We ran 100,000
simulations randomly placing 600 microdeletions of 2kb lengths
and determined how many times a microdeletion spanned an
exon. In this way, we demonstrated that complete (homozygous)
microdeletions under 10kb in size spanned exons slightly more
often than by chance with a simulated p-value of .046. Similar
assessment of microdeletions greater than 10kb in size did not find
evidence of enrichment. These findings suggest that small
microdeletions may preferentially occur within genes as opposed
to being randomly distributed across the genome, but the signal is
Figure 6. Reads spanning interchromosomal translocation breakpoints. Two genomic breakpoint events are highlighted between
chromosomes 2 and 16. The outer ring represents the chromosomes displaying tick marks every 100 bases. The green plot shows base-coverage for
each position. Each orange line represents a single mate-pair as a link between one end of a read and its mate-pair. Between the breakpoints on each
chromosome (chr2:56792000–56953300 and chr16:8826200–8826700), base coverage drops to about half of what it is on the other side of the event,
from two to one copy. This suggests an interchromosomal translocation between chromosomes 2 and 16 resulting in a loss of the genomic material
between the translocation breakpoints.
doi:10.1371/journal.pgen.1000832.g006
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variations are summarized in Table S4.
Annotation of Relevant Mutated Genes
The annotation tool DAVID was used to further examine the
biological significance of the list of likely knockout mutations
(including genes affected by SNVs, indels, microdeletions and
translocation events) using the EASE analysis module. After gene
ontology (GO) analysis, 18 GO terms were nominally enriched
and associated with the mutated gene with a p-value ,=0.01
(Table S5). These GO enrichments include cell adhesion
(GO:0007155 and GO:0022610), membrane (GO:0044425), and
protein kinase regulator activity (GO:0019887).
The list of genes was also compared to the list of cancer-
associated genes maintained by the Cancer Gene Census project
(http://www.sanger.ac.uk/genetics/CGP/Census/). For SNVs
and small indels, eight were observed in the census list, but this
is not unexpected given the large number of mutations found in
this cell line (p=0.21). Two CGC genes were affected by complete
microdeletions (CDKN2A and MLLT3), and one gene each was
affected by heterozygous microdeletions (IL21R) and interchro-
mosomal translocations (SET). These included genes previously
annotated as mutated in instances of T cell prolymphocytic
leukemia (TCRA and MLLT3), glioma (PTEN), endometrial
cancer (PTEN), anaplastic large-cell lymphoma (CLTCL1),
prostate cancer (ETV1 & PTEN), Ewing sarcoma (FLI1 and
ETV1), desmoplastic small round cell tumor (FLI1), acute
lymphocytic leukemia (FLI1 and MLLT3), clear cell sarcoma
(FLI1), sarcoma (FLI1), myoepithelioma (FLI1), follicular thyroid
cancer (PAX8), non-Hodgkin lymphoma (IL21R), acute myelog-
enous leukemia (SET), fibromyxoid sarcoma (CREB3L2), mela-
noma (XPC), and multiple other tumor types (PTEN and
CDKN2A).
We also explored the overlap of genes with mutations in GBMs
according to the Cancer Genome Atlas (TCGA) with those we
predicted are homozygously loss-of-function mutated in U87MG
(Table S5). Seven genes mutated in U87MG by SNVs or indels
were also found mutated within the TCGA sample (PTEN, LTF,
KCNJ16, ABCA13, FLI1, MLL4, DSP). This overlap is not
statistically significant (p=0.16). Ten additional genes overlapped,
including two genes mutated by interchromosomal translocations
(CNTFR, ELAVL2), three genes mutated by intrachromosomal
translocations (ANXA8, LRRC4C, ALDH1A3), and five by
homozygous microdeletions (CDKN2A, CDKN2C, MTAP,
IFNA21, TMBIM4).
Finally, in order to place the homozygous mutations of U87MG
in context relative to GBM mutational patterns as a whole, the
Genomic Identification of Significant Targets in Cancer (GISTIC)
method [28] was applied to 293 glioblastoma samples with
genome wide copy number information available from the TCGA.
This yielded a list of significant, commonly deleted regions present
across glioblastomas as a group and highlights genes commonly
mutated in GBMs. These data indicate that all or parts of
chromosomes 1, 6, 9, 10, 13, 14, 15, and 22 are commonly deleted
within GBMs as a group. In total, these regions comprise
915,306,764 bases, covering roughly 30 percent of the genome.
In order to highlight genes homozygously mutated in U87MG that
are within the regions of common loss, we cross-referenced these
lists and found that 62/332 (19%) are within the GISTIC defined
regions. This does not suggest a significant overlap of homozy-
gously mutated genes in U87MG with commonly deleted regions,
but those mutated genes that do overlap may be of increased
relevance to cancer. Two of the 62 genes are also in the Cancer
Gene Census: PTEN and TCRA. We propose that a subset of the
genes mutated in U87 within these commonly deleted regions may
be the specific targets of mutation and should be assessed on larger
sample sets. (Table S5 and Figure S4).
Discussion
Reported individual human genome sequencing projects using
massively parallel shotgun sequencing with alignment to the
human reference genome clearly indicate the practicality of
individual whole genome sequencing. However, the monetary cost
of data generation, data analysis issues, and the time it takes to
perform the experiments have remained substantial limitations to
general application in many laboratories. Here we demonstrate
enormous improvements in the throughput of data generation.
Using a mate-pair strategy and only ten micrograms of input
genomic DNA, we generated sufficient numbers of short sequence
reads in approximately 5 weeks of machine operation with a total
reagent cost of under $30,000. We believe this makes U87MG the
least expensive published genome sequenced to date signaling that
routine generation of whole genomes is feasible in individual
laboratories. Further, the two-base encoding strategy employed
within the ABI SOLiD system is a powerful approach for
comprehensive analysis of genome sequences and, in concert with
BFAST alignment software, is able to identify SNVs, indels,
structural variants, and translocations.
Of particular interest in whole-genome resequencing studies
such as this one is how much raw data must be produced to
sequence both alleles using a shotgun strategy. Here, 107.5Gb of
raw data was generated. Of this, 55.51Gb was mapped to unique
positions in the reference genome. In effect, this results in a mean
base coverage of 10.856per allele within non-repetitive regions of
the genome. Repetitive regions are of course undermapped, as
their unique locations are more difficult to determine. This level of
oversampling is adequate for high stringency variant calling (error
rate less than 5610
26) at 93.71% of heterozygous SNP positions.
There may be some biases in library generation resulting in bases
that are not successfully covered even if they are relatively unique,
but solutions to this may be found in performing multiple
sequencing runs with varied library designs, as suggested in other
studies [17].
With rapid advances in the generation of massively parallel
shotgun short reads, one of the major computational problems
faced is the rapid and sensitive alignment of greater than 1 billion
paired end reads needed to resequence an individual genome. We
demonstrate a practical solution using BFAST, which was able to
perform fully gapped local alignment on the two-base encoded
data to maximize variant calling in less than 4 days on a 20-node
8-core computer cluster.
Comparing U87MG SNVs with the James Watson [12] and
YanHuang [14] genome projects’ SNVs displays differences in
SNV detection between the three projects. Being derived from a
Caucasian individual, U87MG and James Watson are expected to
share more SNVs than U87MG and YanHuang. However, when
we compared SNVs between U87MG and these two genomes,
more SNVs were actually shared between U87MG and Yan-
Huang. Meanwhile, the YanHuang project called significantly
more SNVs in total than both our U87MG sequencing project and
the James Watson project. These results stress that utilizing
different sequencing platforms (U87MG-ABI SOLiD, James
Watson-Roche 454, YanHuang-Illumina Solexa), alignment tools
(U87MG-BFAST, James Watson-BLAT, YanHuang-SOAP) and
analytical approaches results in finding different quantities of
SNVs. The higher genomic coverage in our U87MG sequence
relative to James Watson and the increased sensitivity of BFAST
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variants. This is particularly important when sequencing a cancer
genome because of the interest in finding novel cancer mutations
as opposed to common polymorphisms.
The genomic sequence demonstrates global differences in
variant type across the coding and non-coding portions of the
human genome. By increasing the sensitivity of indel detection, we
revealed that small indels have mutated genes at a higher rate than
SNVs. A larger proportion of the indels identified are predicted to
cause a protein coding change compared to SNVs (178/191,743
indels vs. 154/2,384,470 SNVs).
In U87MG, there is a relative increase in 4-base indels genome-
wide, which has been observed in other normal genomes [23–25]
(Figure 2, red bars). However, indels found in coding regions
exhibit a bias toward events that are multiples of 3-bases in length
(Figure 2, blue bars) presumably selected to maintain reading
frame. Thus, many of these events are likely to be polymorphisms
and not disease related genomic mutations [25]. Similarly, the
nucleotide substitution frequencies demonstrate a bias in coding
regions compared to non-coding. Two-thirds of the substitutions
were transitions genome-wide, as expected [27], but there was an
enrichment of CG-.TA transitions in coding regions (Figure 3). It
is well established that the most common source of point mutations
and SNPs in primates is deamination of methyl-cytosine (meC),
causing transition to a thymine (T) [16,29], and there is
circumstantial evidence of that in U87MG’s genome as well.
The resolution of genome-wide chromosomal rearrangements is
substantially improved by the mate-pair strategy, coupled with
sensitive and independent alignment of the short 50-base reads
(Figure 5). Based on published SKY data, we anticipated 7
interchromosomal breakpoints [6]. However, whole-genome
mate-paired sequence data revealed the precise chromosomal
joins of 35 interchromosomal events, which account for previously
observed chromosomal abnormalities in U87MG but at additional
finer scale resolution (Figure 5, Figure 6, Figure 7). The
translocation events were enriched in genic regions with 32/35
(91.4%) occurring within 1kb of genes. A weaker, but still
noticeable enrichment over genes occurs with microdeletions as
well, which are generally missed by other experimental techniques
like DNA microarrays. Thus, within the overall mutational
landscape of this cancer cell line, translocations and structural
variants preferentially occurred over genes, supporting a model
where cancer mutations occur via structural instability rather than
novel point mutations.
Delving into the functional effects of the mutations in U87MG
through gene ontology and cross-referencing the literature, we
found a large number of known and predicted cancer mutations
present in the cell line. There is always a concern when dealing
with a cancer cell line that mutations will be more related to its
status as a cell line than to the cancer it was derived from. While
this remains a concern, the large number of predicted and known
cancer genes present in U87MG suggests other genes mutated in it
have relevance to cancer as well. Using GISTIC to find regions
with common deletions in glioma samples, we highlight 60 genes
that are mutated in U87MG and are located in regions that are
commonly deleted in GBMs that are not included within the
Cancer Gene Census list as potential candidate mutational targets
in GBMs (Table S5).
Cancer cell lines are commonly used as laboratory resources to
study basic molecular and cellular biology. It is clearly preferable
to have complete genomic sequence for these valuable resources.
U87MG is the most commonly studied brain cancer cell line and is
highly cytogenetically aberrant. While this made the sequencing
and mutational analysis more challenging, it serves as a model for
future cultured cell line genomic sequencing. Through custom
analyses, we found that the mutational landscape of the U87MG
genome is vastly more complicated than we would have expected
based on the variants discovered in previously published genomes.
It is our hope that the increased genomic resolution presented here
will direct researchers and clinicians in their work with this brain
cancer cell line to create more effective experiments and lead to a
greater ability to draw meaningful conclusions in the future.
Materials and Methods
Data Sources
The NCBI reference genome (build 36.1, hg18, March 2006),
genomeannotations, and dbSNPversion 129 weredownloaded from
the UCSC genome database located at http://genome.ucsc.edu. A
local mirror of the UCSC genome database (hg18) was used for the
subsequent analysis of variants using included gene models and
annotations. The Watson genome variants were downloaded from
Cold Spring Harbor Laboratory (http://jimwatsonsequence.cshl.
edu) with bulk data files availablefrom ftp://jimwatsonsequence.cshl.
edu/jimwatsonsequence/. The YanHuang variants were download-
ed from the Beijing Genomics Institute at Shenzhen (http://yh.
genomics.org.cn/) with bulk data files available from http://yh.
genomics.org.cn/download.jsp.
Sample Preparation
U87MG cells were ordered from ATCC (HTB-14) and cultured
in a standard way. Genomic DNA was isolated from cultured
U87MG cells using Qiagen Gentra Puregene reagents. DNA was
stored at 220C until library generation.
ABI Sequencing
Long-Mate-Paired Library Construction: The U87MG geno-
mic DNA 26 50bp long mate-paired library construction was
carried out using the reagents and protocol provided by Applied
Biosystems (SOLiD 3 System Library Preparation Guide). A
similar protocol was reported previously [17]. Briefly, 45ug of
genomic DNA was fragmented by HydroShear (Digilab Genomic
Solutions Inc) to 1.0–2.5kb. The fragmented DNA was repaired by
the End-It DNA End-Repair Kit (Epicentre). Subsequently, the
LMP CAP adaptor was ligated to the ends. DNA Fragments
between 1.2–1.7kb were selected by 1.0% agarose gel to avoid
concatamers and circularized with a biotinylated internal adaptor.
Non-circularized DNA fragments were eliminated by Plasmid-
Safe ATP-Dependent DNase (Epicentre) and 3ug of circularized
DNA was recovered after purification. Original DNA nicks at the
Figure 7. Increased resolution of structural variations by
sequencing. Resolution of karyotyping and SKY approaches is not
high enough to see the complex nature of this translocation event
between chr1 and chr16. With high-resolution whole-genome sequenc-
ing, the true structure of the translocation is revealed as mutual
translocations between a small fragment of chr2 with chr1 and chr16 on
either end.
doi:10.1371/journal.pgen.1000832.g007
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target genomic DNA about 100bp by nick translation using E. coli
DNA polymerase I. Fragments containing the target genomic
DNA and adaptors were cleaved from the circularized DNA by
single-strand specific S1 nuclease. P1 and P2 adaptors were ligated
to the fragments and the ligated mixture was used to create two
separate libraries with 10 cycles of PCR amplification. Finally,
250–300bp fragments were selected to generate mate paired
sequencing libraries with average target genomic DNA on each
end around 90bp by excision from PAGE gel and use as emulsion
PCR template. Templated Beads Preparation: The templated
beads preparation was performed using the reagents and protocol
from the manufacturer (Applied Biosystems SOLiD 3 Templated
Beads Preparation Guide). SOLiD 3 Sequencing: The 2650b
mate-paired sequencing was performed exactly according to the
Applied Biosystems SOLiD 3 System Instrument Operation Guide
and using the reagents from Applied Biosystems.
Exon Pull-Down Capture Sequencing with Illumina GAII
We used an array pull-down capture strategy established in our
lab [30]. An Agilent custom array for capturing 5,253 ‘‘cancer-
related’’ genes was designed through Agilent e-array system (www.
agilent.com). Only the amino acid encoding regions were targeted
with 60mer oligos spaced center-to-center 20–30bp. The probes
were randomly distributed across two separate 244K arrays. The
library for cancer gene capture sequencing was generated
following the standard Illumina paired-end library preparation
protocol. 5ug of genomic DNA was used for the starting material
and 250–300bp fragments were size-selected during the gel-
extraction step. In the last step, 18 cycles of PCR were performed
in multiple tubes to yield 4ug of product and mixed with 50ug of
Human Cot-1 DNA (Invitrogen), 52ul of Agilent 106 Blocking
Agent, 260ul of Agilent 26Hybridization Buffer and 106molar
concentration of unpurified Illumina paired-end primer pairs
custom made according to the sequences provided by Illumina
(Oligonucleotide sequences, 2008, Illumina, Inc: available on
request from Illumina). The mix was then diluted with elution
buffer for the final volume of 520ul and then incubated at 95uC for
3 min and 37uC for 30min. 490ul of the hybridization mix was
added to the array and hybridized in the Agilent hybridization
oven (Robins Scientific) for 65 hrs at 65uC, 20rpm. After
hybridization, the array was washed according to the Agilent
wash procedure A protocol. The second wash was extended to
5 minutes to increase the wash stringency. After washing, the
array was stripped by incubating it in the Agilent hybridization
oven at 95uC for 10min, 20rpm with 1.096Titanium Taq PCR
Buffer (Clonetech). After the incubation and collection of the
solution, 4 tubes of PCR were performed with each tube
containing 96ul of the collected solution, 1ul of dNTPs (10mM
each), 1ul of Titanium Taq (Clonetech) and Solexa primers, 1ul
each. 15 cycles of PCR was performed at the following condition:
30sec at 95uC, (10 sec at 95uC, 30 sec at 65uC, 30 sec at
72uC)618 cycles, 5 min at 72uC and hold at 4uC. The amplified
product was purified using QIAquick PCR Purification Kit and
eluted in 30ul of EB. After confirming the size of the amplicon on
2% agarose gel and measuring the concentration, the amplicon
was diluted to 10nM, the working concentration for cluster
generation. The Illumina flowcell was prepared according to the
manufacturer’s protocol and the Genome Analyzer was run using
standard manufacturer’s recommended protocols. The image data
produced were converted to intensity files and were processed
through the Firecrest and Bustard algorithms (1.3.2) provided by
Illumina to call the individual sequence reads.
ABI SOLiD Sequence Alignment and Consensus Base
Calling
We used Blat-like Fast Accurate Search Tool version 0.5.3
(BFAST http://bfast.sourceforge.net) [19] to perform sequence
alignment of the two-base encoded reads off the ABI SOLiD to the
NCBI human reference genome (build 36.1). Utilizing the local
alignment algorithm included in BFAST [31], we were able to
simultaneously decode the short reads, while searching for color
errors (encoding errors), base changes, insertions, and deletions.
We found candidate alignment locations (CALs) for each end
independently. We utilized ten indexes to be robust to up to six











We also set parameters to use only informative keys when
looking up reads in each index (BFAST parameter -K 8), and to
ignore reads with too many CALs aggregated across all indexes
(BFAST parameter -M 384). If reads mapped to greater than 384
locations, then they were categorized as ‘unmapped’. We then
performed local alignment for each of the returned CALs,
simultaneously decoding the read from color space searching for
color errors (encoding errors), base changes, insertions, and
deletions [31]. We choose the ‘‘best scoring’’ alignment, accepting
an alignment only if it was at least the equivalent edit distance of
two color errors away from the next best alignment. This is
approximately similar to a ‘mapping quality’ of 20 or better from
the MAQ program output, for reference. We removed duplicate
reads using the alignment filtering utility found in DNAA (http://
dnaa.sourceforge.net). For single-end and mate-paired reads
where only one end mapped, we removed duplicates based on
reads having identical stat positions. For mate-paired reads, we
removed duplicates where both ends had the same start position.
Illumina Genome Analyzer Sequence Alignment
Illumina generated sequence was aligned to the NCBI human
reference genome (build 36.1) using BFAST with the following
parameters applied. Each end of the fragment library was mapped
independently to identify CALs, utilizing ten indexes to be robust











We also set parameters to use only informative keys when
looking up reads in each index (BFAST parameter -K 8), and to
ignore reads with too many CALs aggregated across all indexes
(BFAST parameter -M 1280). We then performed a standard local
alignment for each CAL. Reads were declared mapped if a single
unique best scoring alignment was identified within the genome.
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ABI SOLiD data.
Single Nucleotide Variant and Small Insertion and
Deletion Detection
To find SNVs including SNPs and small indels, we assumed the
MAQ consensus-calling model [20] utilizing the implementation
in SAMtools [21]. We used a value of 0.0000007 for the prior of a
difference between two haplotypes (-r parameter). This was chosen
based on ROC analysis of a test dataset (data not shown).
Structural Variation Detection
Structural variations were detected using custom algorithms
designed to comprehensively search for groups of mate-pair reads
with aberrant paired-end insert size distributions that are consis-
tently identifying a unique structural variant in the genome. We
utilized the ‘‘dtranslocations’’ utility in the DNAA package (http://
dnaa.sourceforge.net) for the primary structural variation candidate
search. The utility first selected all pairs for which each end is
uniquely mapped to a single location in the human genome and for
which the mate-pair reads are not positioned in the expected size
range relative to the consensus genome. Then we filter out false
positives that are not consistent with a chromosomal difference on
an allele. Briefly, the genome was divided into 500-base bins
sequentially stepped 100-bases apart from their start positions. Each
bin was then paired with other bins on the basis of containing
similar ‘mismapped’ mate-pair reads. The aberrant mate-paired
reads were defined as reads that were mapping less than 1000 or
greater than 2000 bases apart within the reference genome
sequence, which is selected based on the insert size distribution
calculated from the aggregate dataset (Figure S2). These were then
rank-ordered based on the number of mate-pairs meeting criteria,
and the destination binwith the most reads withinit was paired with
a given source bin to create a ‘binset’. Binsets containing less than 4
reads were filtered out, removing 98.3% of the candidates based on
having too little evidence supporting them. The resulting list of
filtered binsets was then scanned for clusters of binsets. Binset
clusters are groups of binsets where the source bins occur within
2000 bases of each other and the destination bins occur within 2000
bases of each other. Redundant binsets were combined and those
binset clusters that contain too few (less than 9 binsets spanning at
least 1000 bases) or too many binsets (greater than 29 binsets
spanning at most 3000 bases—higher is impossible given our insert
size distribution) were removed as artifacts. The resulting binset
clusters represent the reads immediately flanking structural break-
point events. This detection process is currently being automated as
Breakway (http://breakway.sourceforge.net), but was done using
custom scripts at the time of analysis.
The structural variations were then separated into interchro-
mosomal and intrachromosomal events. Intrachromosomal events
of less than 1Mb are assessed for deletion status by averaging base
coverage within the bounds of the event and comparing it to base
coverage 200kb outside the event on both sides. Those that have
average interior base coverage less than 25% of the average
exterior base coverage are classified as ‘‘complete’’ deletions.
Those with average interior base coverage between 25% and 75%
that of average exterior base coverage are classified as ‘‘hetero-
zygous deletions’’ (deletions of at least one copy of the region, but
with at least one copy remaining).
Genes Affected by Mutations in Coding Sequence
Variant calls from the SAMtools pileup tool were first loaded
into a SeqWare QueryEngine database and subsequently filtered
to produce BED files. This filtering criteria required that a variant
be seen at least 4 times and at most 60 times with an observation
occurring on each strand at least once. For SNVs we further
enforced the criteria that SNVs should only be called in reads
lacking indels and the last 5 bases of the reads were also ignored.
This reduced the likelihood that spurious mismappings were used
to predict SNVs and eliminated the lowest quality bases from
consideration. For small indels (,21bp) we enforced a slightly
different filter by requiring that any reads supporting an indel were
only allowed to contain one contiguous indel and these reads were
not considered if the indel occurred on either the beginning or end
of the read. These criteria, like the SNV criteria, were used to
reduce the likelihood of using mismapped reads or locally
misaligned reads in the variant calling algorithm. The elimination
of reads with indels at the beginning or end of the read was
intended to remove potential alignment artifacts caused by
ambiguous gap introduction due to lack of information at the
ends to guide proper alignment. Together, these filtering criteria
reduced the likelihood that sequencing errors were identified as
SNV or indel variants. We used scripts available in the BFAST
toolset and SeqWare Pipeline to filter and annotate the variant
calls. Variants passing these filters were further annotated by their
overlap with dbSNP version 129. Variants were required to share
the same genomic position as a dbSNP entry along with matching
the allele present in the database to be considered overlapping.
Mapping to dbSNP allowed us to filter out known SNPs from de
novo variants.
Filtered SNV and indel variants were then analyzed for their
affect within the genome that is annotated with gene models. This
analysis used scripts from the SeqWare Pipeline project and gene
models downloaded from the UCSC hg18 human genome
annotation database. Six different gene model sets from hg18
were considered: UCSC genes (knownGene), RefSeq genes
(refGene, http://www.ncbi.nlm.nih.gov/RefSeq), Consensus
Coding Sequence genes (ccdsGene, http://www.ncbi.nlm.nih.
gov/CCDS), Mammalian Gene Collection genes (mgcGenes,
http://mgc.nci.nih.gov), Vertebrate Genome Annotation genes
(vegaGene, http://vega.sanger.ac.uk), and Ensembl genes (en-
sGene, http://www.ensembl.org). Each variant was evaluated for
overlap with genes from each of the 6 gene models. If overlap was
detected the variant was examined and tagged with one or more of




tion’’, ‘‘inframe-indel’’, ‘‘intron-splice-site-mutation’’, ‘‘stop-co-
don-loss’’, and/or ‘‘start-codon-loss’’. The variant was also tagged
with the gene symbol and other accessions to facilitate lookups.
This information was loaded into a SeqWare QueryEngine
database to allow for querying and filtering of the variants as
needed.
Genes affected by structural variations were assessed in two
ways depending on the structural variation type. For interchro-
mosomal translocation events, a gene was considered ‘‘affected’’
when either end of an interchromosomal translocation event fell in
a genic region (including the entire coding region plus 1kb up- or
down-stream of the gene’s coding region). The same criteria were
used for all intrachromosomal translocation events. For events that
were classified as complete or heterozygous deletions, a gene was
considered affected if all or part of a coding exon was deleted.
Annotation of Relevant Mutated Genes
Homozygous SNVs, small indels, large deletions, and translo-
cation events for variants that included predicted coding sequence
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serious homozygous mutations that likely completely disrupted, or
‘‘knocked out’’, the normal function or synthesis of the target
protein.
For the SNVs and small indels, a ‘‘knockout’’ variant was
defined as a homozygous call by the SAMtools variant caller
where the variant was predicted by the SeqWare Pipeline scripts to
change coding sequence with one or more of the following
annotations: ‘‘early-termination’’, ‘‘frameshift’’, ‘‘intron-splice-site-
mutation’’, ‘‘start-codon-loss’’, and/or ‘‘stop-codon-loss’’. The
‘‘early-termination’’ event represented a stop codon introduced
upstream of the annotated stop codon. The ‘‘frameshift’’
represented an indel that resulted in a shifting of the reading
frame of the gene resulting in, typically, early termination and
non-sense coding sequence. The ‘‘intron-splice-site-mutation’’
referred to a mutation in the two consensus splice site intronic
bases flanking exons (GT at the 59 splice site and AG at the 39
splice site). Finally, ‘‘stop-codon-loss’’ and ‘‘start-codon-loss’’
simply refer to variants that interrupt the stop or start codons.
We chose to not include ‘‘coding-nonsynonymous’’ and ‘‘inframe-
indel’’ annotations in this list of knocked out variants because,
while potentially serious as these mutations are, they are not
guaranteed to result in an unexpressed or non-functional protein.
However, homozygous frameshift, early termination, splice site,
and stop/start codon loss mutations are very likely to interrupt a
gene’s expression and translation to functional protein.
As described above, large microdeletions that removed all or
part of an exon and interchromosomal translocation events that
fell within 1kb of a gene’s coding region were also classified as
mutated genes.
Once suspect knockout variants were identified, a mapping
process was used to translate one or more variants to the gene
symbol. This mapping allowed us to condense multiple variants
affecting multiple gene models to a more abbreviated list of gene
symbols likely to be affected by these knockout mutations. The
mapping from variants to gene symbols used variants identified
with gene models from the refGene and the knownGene tables in
the UCSC hg18 database and mapped these variants to gene
symbols using queries against the name field of the knownGene
table and the alias field of the kgAlias table. The UCSC table
browser was used to accomplish these queries and map the
knownGene identifiers to gene symbols via the kgXref table. A
similar approach was used for homozygous large-scale microdele-
tions and translocation events.
DAVID/EASE Analysis
The list of knockout genes was uploaded to the Database for
Annotation, Visualization, and Integrated Discovery (DAVID,
version 2008) to identify enriched Gene Ontology (GO) terms
[32–33]. Overlap with GO terms from the biological process,
cellular component, and molecular function ontologies were
considered. The default parameters were used and a p-value
cutoff of ,=0.01 was considered significant.
Cancer Gene Census
The overlap between the Cancer Gene Census genes and those
identified as knockouts in U87MG were compared. The Cancer
Gene Census project is an ongoing effort to catalog genes with
mutations that have been implicated in cancer [34]. It is a highly
curated list that includes annotations for each gene including
tumor types, class of mutations, and other genetic properties. We
used the gene symbol list from the September 30
th, 2009 complete
working list, which includes 412 gene symbols.
TCGA
The overlap between mutations in the Cancer Genome Atlas
(TCGA) and those identified as knockouts in U87MG was
analyzed. TCGA is an ongoing effort to understand the molecular
basis of cancer through large-scale copy number analysis,
expression profiling, genome sequencing, and methylation studies
among other techniques [4]. It provides information on mutations
found by Sanger sequencing on many patient samples. For
glioblastoma this includes sequence data aberrations detected in
158 patient samples and 1,177 genes.
Genomic Identification of Significant Targets in Cancer
The Genomic Identification of Significant Targets in Cancer
(GISTIC) method was used to find significant areas of deletion in
293 samples from the TCGA [24]. The GISTIC technique was
designed to identify and analyze chromosomal aberrations across a
set of cancer samples, based on the amplitude of the aberrations as
well as the frequency across samples. This approach produced a
series of commonly deleted regions across the set of TCGA GBMs.
To calculate the areas of deletion, we used 293 Affymetrix SNP
6.0 samples segmented using the GLAD SNP analysis module
[35]. Default parameters of GISTIC were used. GISTIC produces
peak limits, wide peak limits, and in addition broader region limits.
These commonly deleted broader regions were then scanned for
predicted knockout genes in U87MG.
Indel Size Distribution and Nucleotide Substitution
Frequencies
The distribution of small indel sizes was examined for both
deletions and insertions. Indels classified as affecting coding-
sequence by the SeqWare Pipeline (see above) were compared to
those outside coding regions. Raw counts were collected,
recalculated as percents of total, and compared directly.
Similarly, nucleotide substitution frequency was examined for
SNVs from U87MG both genome-wide and only in coding
regions. Once binned appropriately, the SNV nucleotide substi-
tutions were counted, tallied in a table, and graphed as percents of
total.
Individual Genome Comparison
Variants from the Watson and Yan Huang genome were
downloaded from each respective project from the following
URLs: ftp://jimwatsonsequence.cshl.edu/jimwatsonsequence/
watson-454-snp-v01.txt.gz and http://yh.genomics.org.cn/do.
downServlet?file=data/snps/yhsnp_add.gff. These files contained
variant calls for each genome along with annotations describing
the variant as novel or occurring in dbSNP. The Watson genome
only contained SNV calls so our comparison was limited to just
SNVs. The Yan Huang genome also contained calls indicating
heterozygous or homozygous. However, a variant was considered
to match between genomes regardless of zygosity state. We
compared the overlap of the U87MG genome, dbSNP and each of
these genomes in turn. SNVs from U87MG that were considered
for comparison had to meet our criteria; variants had to be
observed at least 4 times, at most 60 times, at least once per strand,
and with a minimum phred score of 10. SNVs in the three-way
comparison were said to match if the position and allele matched
between the genomes. If both variants matched between U87MG
and the other genome and one was annotated in dbSNP, then the
other was considered in dbSNP as well. If neither contained
annotations from dbSNP the variant was considered novel. A
similar process was carried out for variants distinct to each
genome. The results were recorded as Venn diagrams showing the
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Illumina SNP Chip
Genomic DNA from U87MG was submitted to the Southern
California Genotyping Consortium to be run on the Illumina
Human 1M-Duo BeadChip, which consists of 1,199,187 probes
scattered across the human genome. The Illumina Beadstudio
program was used to analyze the resulting intensity data. Loss of
heterozygosity was determined by analyzing B-allele frequency as
determined by the Beadstudio program. Normal two-copy regions
of the genome are represented by long stretches of probes with B-
allele frequencies of 0, 0.5 or 1. Regions of LOH, on the other
hand, deviate from this pattern significantly. Copy number was
determined by looking at probe intensity.
Sanger Sequencing Validation
Primers for validation were designed by targeting regions
immediately flanking the event predicted by our whole genome
sequence analysis using the Primer3 tool (http://frodo.wi.mit.ed/
primer3/). Polymerase chain reaction was performed following
standard protocols using Finnzymes Phusion Hot-Start High
Fidelity polymerase. Products were run on 2% agarose gel
electrophoresis and product purity and size was assessed by
staining with ethidium bromide. Sanger sequencing was per-
formed at the UCLA Genotyping and Sequencing core facility
using an ABI 3730 Capillary DNA Analyzer. Sequence trace files
were analyzed using Geospiza FinchTV. Validation status and
PCR primers are listed in Table S1.
Data Deposition and Availability
Intensities, quality scores, and color space sequence for the
genomic sequence of U87 SOLiD were uploaded to the Sequence
Read Archive under the accession SRA009912.1/Sequence of
U87 Glioblastoma Cell-line. Intensities, quality scores, and
nucleotide space sequence for the exon capture U87 Illumina
sequence were also uploaded to the Short Read Archive under the
same accession. For both datasets, alignment files have been
uploaded to the Short Read Archive as additional analysis results.
Variant calls for both datasets are available via a SeqWare
QueryEngine web service at http://genome.ucla.edu/U87. This
tool allows for querying the variants using a variety of search
criteria including coverage, mutational consequence, gene symbol,
and others. SeqWare QueryEngine produces results in both BED
and WIG format making it compatible with the majority of
genome browsers such as the UCSC genome and table browsers.
Variant data will be uploaded to SRA as metadata along with the
raw sequences. For the whole genome SOLiD alignment, small
indels (,21bp), SNVs, large deletions, and translocation events
can be queried. For the exon capture Illumina alignment, small
indels and SNVs can be queried.
Software Availability
Most software used for this project is open-source and freely
available. We created two software projects that were instrumental
in the analysis of the U87MG data: BFAST and SeqWare. The
color- and nucleotide-space alignment tool BFAST can be
downloaded from http://bfast.sourceforge.net and many of our
alignment filtering as well as the primary step in structural
variation detection can be found in the DNAA package at http://
dnaa.sourceforge.net. The SeqWare software project was used
throughout the analysis of variant calls. We used the SeqWare
LIMS tool for sample tracking, the SeqWare Pipeline analysis
programs for annotating variants with dbSNP status and
mutational consequence predictions, and SeqWare QueryEngine
was used to database and query variant calls and annotations. This
software and documentation can be downloaded from http://
seqware.sourceforge.net.
Supporting Information
Figure S1 Concordance between Solexa capture data and
SOLiD whole genome data. The left plot displays the SNP call
concordance between each experiment (Solexa capture data in
blue, SOLiD whole genome data in red) with the Illumina 1M
Beadchip microarray for the 8.5Mb of sequence pulled down in
the capture experiment. The right plot displays concordance of the
non-reference (mutant) allele calls with the array data for those
regions.
Found at: doi:10.1371/journal.pgen.1000832.s001 (0.43 MB TIF)
Figure S2 Paired end insert size distribution. Empirical paired
end insert size distribution for reads where both ends aligned with
duplicates removed.
Found at: doi:10.1371/journal.pgen.1000832.s002 (0.41 MB TIF)
Figure S3 Alignment is robust against genome-wide repeat
elements. Circos plot [35] of reads spanning a complete
microdeletion on chromosome 2, bases 201855000–201858000,
are shown in dark blue, with the normal reads in the surrounding
region in light blue. The green plot shows base-coverage at each
position. The outermost track shows the structure of a gene,
CASP8, overlapping this region (large boxes-exons, lines-introns).
The track containing black and red boxes shows genome-wide
repeat elements (black-LINE, red-SINE). Note the high density of
reads even over conserved LINE elements. Some SINE elements
do demonstrate a drop in alignments, but these do not prevent the
identification of structural variation-spanning reads.
Found at: doi:10.1371/journal.pgen.1000832.s003 (0.21 MB TIF)
Figure S4 Commonly deleted regions in GBM according to
GISTIC. This deletion plot shows significant regions of deletion in
293 GBM samples from the TCGA. The top of the plot shows the
G-score and the bottom shows the q-values. G-score reflects the
frequency and amplitude of the deletion. Q-values greater than
0.25 were considered significant. Overlap of genes mutated in U87
via SNVs or Indels and broad regions of deletion are considered to
be likely cancer targets. This includes all or part of chromosomes
1, 6, 9, 10, 13, 14, 15, and 22.
Found at: doi:10.1371/journal.pgen.1000832.s004 (0.43 MB TIF)
Table S1 PCR and dideoxy sequencing validation. A list of the
variants that were validated by PCR and dideoxy sequencing
including primers used, varient location, and validation status.
Found at: doi:10.1371/journal.pgen.1000832.s005 (0.03 MB
XLS)
Table S2 Structural variants in U87MG. All structural variants
listed as regions immediately flanking the genomic breakpoint.
Found at: doi:10.1371/journal.pgen.1000832.s006 (0.18 MB
XLS)
Table S3 Genes knocked out by SNVs/Indels. List of all genes
predicted to be knocked out by SNVs and Indels in U87MG.
Found at: doi:10.1371/journal.pgen.1000832.s007 (0.20 MB
XLS)
Table S4 Genes affected by structural variants. List of all genes
predicted to be affected by structural variants in U87MG.
Found at: doi:10.1371/journal.pgen.1000832.s008 (0.48 MB
XLS)
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to be mutated in U87MG annotated by various cancer-related
gene databases.
Found at: doi:10.1371/journal.pgen.1000832.s009 (0.17 MB
XLS)
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